Google
CRMD — CORMEDIX INC (Healthcare >> Biotechnology)
CRMD FAQ
What is CRMD's P/E ratio?
CORMEDIX INC (CRMD) currently trades at a P/E ratio of 3.75.
What is CRMD's ROE?
CORMEDIX INC reports a Return on Equity (ROE) of 41.42%.
What is CRMD's dividend yield?
CORMEDIX INC offers a dividend yield of 0.00%.
What is CRMD's Deepscope Quality Score?
Deepscope rates CRMD's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CRMD?
Deepscope's AI Timing Score for CRMD is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CRMD belong to?
CORMEDIX INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 8.77
Price
0.12
(1.39%)
Day Change
|
|
|---|
CRMD, the overall quality is not quite good ( Quality = 54) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
58% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
74
GOOD
|
| Magic Formula Rank by ROE |
74
GOOD
|
| Magic Formula Rank by ROIC |
138
|
| Price | 8.77 |
| PBV / Sector |
1.55 / 4.79
GOOD
|
| Earning Per Share | 2.34 |
| PE / Sector |
3.75 / 17.89
GREAT
|
| PEG or PE/Growth / Sector |
-0.01 / 0.56
|
| Average 1M Daily Value |
11.99 M
GREAT
|
| Average 1W Daily Value |
11.61 M
GREAT
|
| Timing Factors |
|
85% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-11 09:54:42 |
| Symbol | CRMD |
| Name | CORMEDIX INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 78.45 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 678.61 / 8,963.32 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 389 Interpace Pkwy, Parsippany, NJ, United States, 07054
Phone: 908 517 9500
Website: https://cormedix.com
Employees: 191
Sector: Healthcare >> Biotechnology
Description: CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
